Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria

B Gao, RS Gupta - Microbiology and molecular biology reviews, 2012 - Am Soc Microbiol
The phylum Actinobacteria harbors many important human pathogens and also provides
one of the richest sources of natural products, including numerous antibiotics and other …

Methodological and clinical aspects of the molecular epidemiology of Mycobacterium tuberculosis and other mycobacteria

T Jagielski, A Minias, J van Ingen… - Clinical microbiology …, 2016 - Am Soc Microbiol
Molecular typing has revolutionized epidemiological studies of infectious diseases,
including those of a mycobacterial etiology. With the advent of fingerprinting techniques …

CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis

JW Ai, X Zhou, T Xu, M Yang, Y Chen… - Emerging microbes & …, 2019 - Taylor & Francis
Rapid and simple-to-use diagnostic methods for tuberculosis are urgently needed. Recent
development has unveiled the diagnostic power of the CRISPR system in the detection of …

TubercuList–10 years after

JM Lew, A Kapopoulou, LM Jones, ST Cole - Tuberculosis, 2011 - Elsevier
TubercuList (http://tuberculist. epfl. ch/), the relational database that presents genome-
derived information about H37Rv, the paradigm strain of Mycobacterium tuberculosis, has …

[HTML][HTML] Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis

A Watson, H Li, B Ma, R Weiss, D Bendayan… - Nature …, 2021 - nature.com
Mycobacterium tuberculosis (Mtb) exposure drives antibody responses, but whether patients
with active tuberculosis elicit protective antibodies, and against which antigens, is still …

Microevolution of extensively drug-resistant tuberculosis in Russia

N Casali, V Nikolayevskyy, Y Balabanova… - Genome …, 2012 - genome.cshlp.org
Extensively drug-resistant (XDR) tuberculosis (TB), which is resistant to both first-and
second-line antibiotics, is an escalating problem, particularly in the Russian Federation …

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis

S Zhang, J Chen, W Shi, W Liu, W Zhang… - Emerging microbes & …, 2013 - Taylor & Francis
Pyrazinamide (PZA) is a frontline anti-tuberculosis drug that plays a crucial role in the
treatment of both drug susceptible and multidrug-resistant tuberculosis (MDR-TB) …

Variation among Genome Sequences of H37Rv Strains of Mycobacterium tuberculosis from Multiple Laboratories

TR Ioerger, Y Feng, K Ganesula, X Chen… - Journal of …, 2010 - Am Soc Microbiol
The publication of the complete genome sequence for Mycobacterium tuberculosis H37Rv
in 1998 has had a great impact on the research community. Nonetheless, it is suspected that …

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis

W Shi, J Chen, J Feng, P Cui, S Zhang… - Emerging microbes & …, 2014 - Taylor & Francis
Pyrazinamide (PZA) is a frontline anti-tuberculosis drug that plays a crucial role in the
treatment of both drug-susceptible and multidrug-resistant tuberculosis (MDR-TB). PZA is a …

Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis

S Zhang, J Chen, P Cui, W Shi… - Journal of …, 2015 - academic.oup.com
Objectives Although clofazimine has been traditionally used to treat leprosy, there is recent
interest in using clofazimine for the treatment of MDR-TB and drug-susceptible TB. However …